Skip to content
10-Q

Quarterly Report

US-China Biomedical Technology, Inc.

0001683168-19-002275

← back to feed
Filed
Jul 22, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Jul 22, 2019 19.8M sh
Operating Cash Flow Q1 2020 · May 31, 2019 −$108.2K
Operating Cash Flow Q1 2020 · May 31, 2018 −$121.73K
Stockholders Equity Q1 2020 · May 31, 2019 $93.21K
Stockholders Equity Q1 2020 · Feb 28, 2019 $1.41K
Stockholders Equity Q1 2020 · May 31, 2018 $437.71K
Stockholders Equity Q1 2020 · Feb 28, 2018 −$271.81K
Current Liabilities Q1 2020 · May 31, 2019 $254.25K
Current Liabilities Q1 2020 · Feb 28, 2019 $76.08K
Total Liabilities Q1 2020 · May 31, 2019 $394.66K
Total Liabilities Q1 2020 · Feb 28, 2019 $76.08K
Current Assets Q1 2020 · May 31, 2019 $155.02K
Current Assets Q1 2020 · Feb 28, 2019 $58.27K
Total Assets Q1 2020 · May 31, 2019 $487.87K
Total Assets Q1 2020 · Feb 28, 2019 $77.49K
Sga Expense Q1 2020 · May 31, 2019 $122.2K
Sga Expense restated Q1 2020 · May 31, 2018 $86.59K
Net Income Q1 2020 · May 31, 2019 −$122.7K
Net Income Q1 2020 · May 31, 2018 −$274.65K
Operating Income Q1 2020 · May 31, 2019 −$122.2K
Operating Income Q1 2020 · May 31, 2018 −$86.59K
Revenue Q1 2020 · May 31, 2019 $0
Revenue Q1 2020 · May 31, 2018 $0